Overview
Noris Polska represents the Swiss pharmaceutical company NORIS Pharma AG on the Polish market. It develops and adapts a portfolio of OTC products, medical devices and dietary supplements to the needs of Polish patients, including product registration and packaging compliant with Polish requirements. The company sells products to pharmaceutical wholesalers and pharmacies throughout Poland and manages their promotion and advertising.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2001-06-13.
96 1750 0009 0000 0000 0092 7724
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Trademarks
Noris Polska holds 13 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2000.
| Mark | Protected until | |
|---|---|---|
| neodex | Apr 27, 2032 | |
| LANODEX(word) | Apr 13, 2032 | |
| nappikrem | Dec 16, 2030 | |
| NEODEX(word) | Dec 16, 2030 | |
| NAPPIDERM(word) | Dec 16, 2030 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently or a commercial proxy independently is authorized to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sławomir Dąbrowski (61) | 100 | $13,506.21 | 66.6667% |
Krzysztof Bernard Piotrowski (60) | 50 | $6,753.11 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2017-05-17 | Address change (Starościńska 1/15a, 02-516, Warszawa → Ul. Wołoska 22, 02-675, Warszawa) | |
| 2012-08-01 | Share capital change (50,000.00 PLN → 75,000.00 PLN) | |
| 2004-06-18 | Name change ("noris" → "noris Polska") | |
| 2001-05-29 | Entered in the register |
FAQ
Last updated: 2026-10-07